Clinical Trial Update: A Safety and Immunogenicity Study of IVACFLU-A/H5N1 [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating IVACFLU-A/H5N1 for avian influenza with safety and immunogenicity data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• IVACFLU-A/H5N1

Snippet

Sponsor: Institute of Vaccines and Medical Biologicals, Vietnam | Conditions: Avian Influenza | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-04-16